XML 20 R11.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value of Financial Instruments
6 Months Ended
Jul. 02, 2022
Fair Value of Financial Instruments  
Fair Value of Financial Instruments

4. Fair Value of Financial Instruments

The fair values of the Company’s financial instruments are recorded using a hierarchical disclosure framework based upon the level of subjectivity of the inputs used in measuring assets and liabilities. The three levels are described below:

Level 1 – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.

Level 2 – Inputs other than Level 1 that are directly or indirectly observable, such as quoted prices for similar assets or liabilities and quoted prices in less active markets.

Level 3 – Inputs are unobservable for the asset or liability and are developed based on the best information available in the circumstances, which might include the Company’s own data.

4. Fair Value of Financial Instruments (Continued)

The following summarizes the valuation of the Company’s financial instruments (in thousands). The tables do not include either cash on hand or assets and liabilities that are measured at historical cost or any basis other than fair value.

Fair Value Measurements

at July 2, 2022 Using

Quoted Prices in

Significant Other

Active Markets for

Observable

Identical Assets

Inputs

Description

    

(Level 1)

    

(Level 2)

    

Total

Assets:

    

    

    

Cash equivalents:

Money market funds

$

275,655

$

$

275,655

Government debt securities

23,617

5,003

28,620

Corporate debt securities

16,934

16,934

Total cash equivalents

$

299,272

$

21,937

$

321,209

Short-term investments:

Government debt securities

$

211,319

$

92,343

$

303,662

Corporate debt securities

669,183

669,183

Total short-term investments

$

211,319

$

761,526

$

972,845

Total

$

510,591

$

783,463

$

1,294,054

Fair Value Measurements

at January 1, 2022 Using

Quoted Prices in

Significant Other

Significant

Active Markets for

Observable

Unobservable

Identical Assets

Inputs

Inputs

Description

    

(Level 1)

    

(Level 2)

    

(Level 3)

    

Total

Assets:

    

    

    

    

Cash equivalents:

Money market funds

$

845,740

$

$

$

845,740

Corporate debt securities

 

3,552

 

 

3,552

Government debt securities

2,950

2,950

Total cash equivalents

$

845,740

$

6,502

$

$

852,242

Short-term investments:

Government debt securities

$

71,509

$

119,612

$

$

191,121

Corporate debt securities

773,461

773,461

Total short-term investments

$

71,509

$

893,073

$

$

964,582

Other assets, net:

Auction rate securities

$

$

$

4,980

$

4,980

Total

$

$

$

4,980

$

4,980

Total

$

917,249

$

899,575

$

4,980

$

1,821,804

4. Fair Value of Financial Instruments (Continued)

Valuation methodology

The Company’s cash equivalents and short-term investments that are classified as Level 2 are valued using non-binding market consensus prices that are corroborated with observable market data; quoted market prices for similar instruments in active markets; quoted prices in less active markets; or pricing models, such as a discounted cash flow model, with all significant inputs derived from or corroborated with observable market data. Investments classified as Level 3 are valued using a discounted cash flow model. The assumptions used in preparing the discounted cash flow model include estimates for interest rates, amount of cash flows, expected holding periods of the securities and a discount to reflect the Company’s inability to liquidate the securities. The Company’s foreign currency derivative instruments are valued using discounted cash flow models. The assumptions used in preparing the valuation models include foreign exchange rates, forward and spot prices for currencies and market observable data of similar instruments.

Contractual maturities of investments

The Company’s investments are reported at fair value, with unrealized gains and losses, net of tax, recorded as a component of accumulated other comprehensive loss in the Consolidated Balance Sheet. The following summarizes the contractual underlying maturities of the Company’s available-for-sale investments at July 2, 2022 (in thousands):

    

    

Fair

Cost

Value

Due in one year or less

$

582,705

$

577,005

Due after one year through ten years

450,388

440,743

Due after ten years

650

650

$

1,033,743

$

1,018,398

Available-for-sale investments

The available-for-sale investments that were in a continuous unrealized loss position, aggregated by length of time that individual securities have been in a continuous loss position, were as follows (in thousands):

Less Than 12 Months

12 Months or Greater

Total

Gross

Gross

Gross

Fair

Unrealized

Fair

Unrealized

Fair

Unrealized

As of July 2, 2022

    

Value

    

Losses

    

Value

    

Losses

    

Value

    

Losses

Government debt securities

$

304,308

$

(5,200)

$

2,051

$

(60)

$

306,359

$

(5,260)

Corporate debt securities

 

630,420

 

(9,918)

 

9,416

 

(190)

 

639,836

 

(10,108)

$

934,728

$

(15,118)

$

11,467

$

(250)

$

946,195

$

(15,368)

Less Than 12 Months

12 Months or Greater

Total

Gross

Gross

Gross

Fair

Unrealized

Fair

Unrealized

Fair

Unrealized

As of January 1, 2022

    

Value

    

Losses

    

Value

    

Losses

    

Value

    

Losses

Government debt securities

$

126,957

$

(750)

$

$

$

126,957

$

(750)

Corporate debt securities

 

418,917

(1,451)

326

(1)

419,243

(1,452)

Auction rate securities

4,980

(1,020)

4,980

(1,020)

$

545,874

$

(2,201)

$

5,306

$

(1,021)

$

551,180

$

(3,222)

The gross unrealized losses as of July 2, 2022 were due primarily to changes in market interest rates. The gross unrealized losses as of January 1, 2022 were due primarily to changes in market interest rates and the illiquidity of the Company’s auction-rate securities.

4. Fair Value of Financial Instruments (Continued)

The Company records an allowance for credit loss when a decline in investment market value is due to credit-related factors. When evaluating an investment for impairment, the Company reviews factors such as the severity of the impairment, changes in underlying credit ratings, forecasted recovery, the Company’s intent to sell or the likelihood that it would be required to sell the investment before its anticipated recovery in market value and the probability that the scheduled cash payments will continue to be made. As of July 2, 2022, there were no material declines in the market value of available-for-sale investments due to credit-related factors.

At July 2, 2022 and January 1, 2022, there were no material unrealized gains associated with the Company’s available-for-sale investments.

Level 3 fair value measurements

The following summarizes the activity in Level 3 financial instruments for the three and six months ended July 2, 2022 (in thousands):

Assets

Three Months

    

Six Months

Auction Rate Securities

    

Ended

    

Ended

Beginning balance

$

4,944

$

4,980

Sales (1)

(6,000)

(6,000)

Loss recognized in earnings

300

300

Gain included in other comprehensive loss

 

756

 

720

Balance at July 2, 2022

$

$

(1)On May 31, 2022, the Company sold its prior remaining holding of auction-rate securities for $5.7 million.

Fair values of other financial instruments

The Company’s debt is recorded at cost, but is measured at fair value for disclosure purposes. The fair value of the Company’s convertible senior notes is determined using observable market prices. The notes are traded in less active markets and are therefore classified as a Level 2 fair value measurement. As of July 2, 2022 and January 1, 2022, the fair value of the notes was $671.0 million and $944.3 million, respectively.

The Company’s other financial instruments, including cash, accounts receivable and accounts payable, are recorded at amounts that approximate their fair values due to their short maturities.